Company Overview of RFS Pharma, LLC
As of November 25, 2014, RFS Pharma, LLC was acquired by Cocrystal Pharma, Inc. RFS Pharma, LLC, a clinical-stage bio-pharmaceutical company, focuses on developing therapeutics for the treatment of hepatitis viruses and emerging viruses. The company uses its nucleoside chemistry solutions to develop drugs to combat infections caused by drug-resistant HIV and hepatitis viruses. Its products include amdoxovir for the treatment of HIV-1 infections; analogs that are effective against noroviruses; and nucleoside prodrug technology solutions. RFS Pharma, LLC was founded in 2004 and is based in Tucker, Georgia.
1860 Montreal Road
Tucker, GA 30084
Founded in 2004
Key Executives for RFS Pharma, LLC
RFS Pharma, LLC does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact RFS Pharma, LLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.